Thomas Seyfried

Thomas N. Seyfried is an American professor of biology at Boston College , renowned for his research on the metabolic origins of cancer and the application of metabolic therapies to manage chronic diseases such as epilepsy , neurodegenerative disorders, and brain tumors.

Seyfried earned his B.S. from the University of New England , an M.S. in genetics from Illinois State University , and a Ph.D. in genetics and biochemistry from the University of Illinois at Urbana-Champaign in 1976. Following his doctorate, he served as a postdoctoral fellow and assistant professor in the Department of Neurology at Yale University School of Medicine, where he began exploring gene-environmental interactions and lipid biochemistry. His early military service in the U.S. Army's First Cavalry Division during the Vietnam War also shaped his interdisciplinary approach to health and disease.

Throughout his career, Seyfried has authored over 150 peer-reviewed publications, with his work emphasizing cancer as a mitochondrial metabolic disease rather than a primarily genetic one, which he proposes as an alternative to the conventional somatic mutation theory. His seminal 2012 book, Cancer as a Metabolic Disease : On the Origin, Management, and Prevention of Cancer , synthesizes decades of evidence supporting metabolic interventions like ketogenic diets, caloric restriction, and fasting to target tumor energy metabolism while sparing healthy cells. Highly cited studies from his lab, such as "Cancer as a metabolic disease " (2010) and "On the origin of cancer metastasis " (2013), have influenced therapeutic strategies including the "press-pulse" protocol for glioblastoma management. Seyfried serves on editorial boards for journals like Nutrition & Metabolism and ASN Neuro , where he is a senior editor, and has received accolades including the 2013 Alumni Achievement Award from the University of New England, the 2016 Lifetime Achievement Award from the Academy of Comprehensive and Complementary Medicine, and the 2019 Outstanding Career Achievement Award in the Field of Dose Response.

Thomas N. Seyfried was born in 1946 in the United States, where he spent his early years prior to entering military service. Details regarding his family background and specific aspects of his upbringing remain limited in public records.

Seyfried served with distinction in the United States Army's First Cavalry Division during the Vietnam War , a unit renowned for its combat engagements and high decoration rate. He spent approximately one year in Vietnam , performing duties that involved operations from firebases into jungle environments as part of ground forces in active combat zones.

For his valor and service, Seyfried received several military honors, including the Bronze Star, Air Medal , and Army Commendation Medal. These awards recognized his contributions in a conflict that demanded significant personal resilience amid intense and hazardous conditions.

The rigors of his military experience profoundly shaped Seyfried's worldview, fostering an enduring emphasis on health, survival, and human endurance that later influenced his scientific pursuits in addressing life-threatening diseases. He has described his research endeavors as a "different war ," aimed at combating daily threats to human life similar to those faced in Vietnam .

Thomas N. Seyfried completed his undergraduate studies, earning a B.S., at the University of New England, formerly known as St. Francis College in Biddeford, Maine .

He pursued advanced training in genetics , obtaining an M.S. from Illinois State University in Normal, Illinois .

Seyfried then earned his Ph.D. in Genetics and Biochemistry from the University of Illinois at Urbana-Champaign in 1976.